Q1 2021 Marinus Pharmaceuticals Inc Earnings Call Transcript
Greetings, and welcome to the Marinus Pharmaceuticals First Quarter 2021 Business Update call. (Operator Instructions) As a reminder, this conference is being recorded. And it is now my pleasure to introduce your host, Sasha Damouni, Vice President, Investor Relations and Corporate Communications. You may begin, Ms. Damouni.
Thank you. With me from Marinus are Dr. Scott Braunstein, Chief Executive Officer; Dr. Joe Hulihan, Chief Medical Officer; Christy Shafer, Chief Commercial Officer; Steven Pfanstiel, Chief Financial Officer; and Kimberly McCormick, Vice President, Regulatory Affairs.
Before we begin, I would like to remind everyone that some of the statements made today are forward-looking statements under the securities laws. These forward-looking statements involve substantial risks and uncertainties that could cause our clinical development programs, future results, performance or achievements to differ significantly from those expressed or implied by such forward-looking statements. These risks and uncertainties and risks associated with
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
